Viewing Study NCT06769295


Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-01-04 @ 9:14 PM
Study NCT ID: NCT06769295
Status: RECRUITING
Last Update Posted: 2025-01-10
First Post: 2025-01-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
Sponsor: Sichuan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module